Personalized
Dosing
Software
Personalized
Dosing Software
Personalized
Dosing
Software
Accordion header
Implementing personalized protocols allows you to:
- Facilitate implementation of multiple CT abdomen protocol strategies
- Manage cardiac-imaging complexity
- Enable improved protocol adherence
Our workstation helps technologists account for unique patient and study variables. Certegra® P3T personalized CT dosing software personalizes CT protocols for cardiac, pulmonary angiography, and abdomen (liver, pancreas, and kidneys) studies.
Specifically, Certegra® P3T 2.0 enables technologists to:
- Preset radiologist-preferred dosing strategies, contrast concentrations, and scan timing
- Recall up to 250 stored protocols
.
CERTEGRA® P3T 2.0 CARDIAC CT
Comparison of cardiac images and enhancement of coronary tree using P3T protocol versus standard injection protocol.
Control Group 1 received 80 mL of CM at 6 mL/s.
P3T Group injection parameters were individually adjusted to patient weight, the duration of CT data acquisition, and attenuation parameters following a test bolus.
For Control Group 2, the volume of CM was adjusted to the duration of CT data acquisition and injected at 5 mL/s.
Images provided through the courtesy of the University of Muenster.
Used by permission.
CERTEGRA® P3T 2.0 ABDOMINAL CT
The P3T® Abdomen application automatically adjusts contrast volume using an algorithm based on patient, procedure, and prescribed physician parameters.
Images provided during evaluation through the courtesy of Rhode Island Hospital.
Used by permission.
Related Content
Any individuals depicted on this web page are actors and not actual health care providers or patients.
Patient Information listed on the Graphical User Interfaces are fictitious examples only and do not contain any actual patient data.
MRI images throughout this website are actual patient cases but all personal identifiers have been removed or otherwise anonymized. No personally identifiable information is shown.
You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
© 2020-2023 Bayer
BAYER, the Bayer Cross, MEDRAD Stellant, MEDRAD MRXperion, MEDRAD Stellant FLEX, MEDRAD XDS, MEDRAD Veris, MEDRAD Stellant P3T, MEDRAD Spectris Solaris, MEDRAD Spectris, MEDRAD Mark 7 Arterion, MEDRAD Mark V ProVis, MEDRAD Intego, MEDRAD Avanta, MEDRAD Twist & Go, MEDRAD VFlow, Certegra P3T, MEDRAD FluiDots, MEDRAD Vistron, MEDRAD Envision, MEDRAD Certo, MEDRAD, Stellant, MRXperion, Stellant FLEX, Veris, Spectris Solaris, Spectris, Mark 7 Arterion, Mark V ProVis, Avanta, Envision, Twist & Go, VFlow, Radimetrics, Certegra, P3T, Seamlessly Smart, DirectCARE, PartnerCARE, VirtualCare, SelectCARE, and TechCARE are trademarks owned by and/or registered to Bayer in the U.S. and/or other countries.
Bayer HealthCare LLC 100 Bayer Boulevard, PO Box 915, Whippany, NJ 07981
Last update: April 2023